# Effects of Dapagliflozin on Cardiorespiratory Parameters in Heart Failure

> **NCT05770167** · — · UNKNOWN · sponsor: **Centro Cardiologico Monzino** · enrollment: 70 (estimated)

## Conditions studied

- Heart Failure
- Heart Failure With Reduced Ejection Fraction
- Left Ventricle Remodeling
- Sleep Apnea
- Cardiopulmonary Exercise Test

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05770167
- **Lead sponsor:** Centro Cardiologico Monzino
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-06
- **Primary completion:** 2025-04
- **Final completion:** 2025-04
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05770167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05770167, "Effects of Dapagliflozin on Cardiorespiratory Parameters in Heart Failure". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05770167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*